Doximity, Inc. (NYSE:DOCS) is one of the stocks Jim Cramer mentioned in his latest comments. During the lightning round, a caller mentioned that they were not sure if they should sell their position in the stock, and Cramer replied: “No, no, it’s still too expensive, and I didn’t think the quarter was as good as you think. I was actually surprised that this stock ever got as high as it did. I want to wait on that one. I do not want you to buy it here.” Photo by Artem Podrez on Pexels Doximity, Inc. (N ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Micron Technology, Inc. (NASDAQ:MU) is one of the stocks Jim Cramer mentioned in his latest comments. During the episode, a caller asked Cramer where he thinks the business is going in the future. In response, he said: “You know, they do have this one business called the high bandwidth memory, and that is data center, and it is on fire. Sanjay Mehrotra said that could happen. There’s no, I’m not saying there’s no stopping Micron. I am saying that Micron right now is on a high-level run rate that is going ...

Group 1 - Advanced Micro Devices, Inc. (AMD) recently held an important analyst meeting where they announced new long-term financial targets that exceeded market expectations, significantly boosting the stock price [1] - The management provided remarkable growth targets for the next three to five years, indicating strong future performance potential [1] - There has been a noticeable shift in Wall Street sentiment regarding AMD stock in recent weeks, raising questions about its continued upward momentum [1] Group 2 - AMD specializes in manufacturing processors, graphics cards, and AI chips for various applications, including computers, servers, and gaming systems [2] - Key products from AMD include the Ryzen processors, Radeon graphics cards, and EPYC server chips, highlighting the company's diverse product portfolio [2]

Deere & Company (NYSE:DE) is one of the stocks Jim Cramer mentioned in his latest comments. During the episode, a caller asked for Cramer’s thoughts on the stock, and Cramer replied: “You want my thoughts on Deere? [buy, buy, buy] No matter who, no matter what happens in the country, we are a country where farmers get checks, and I think that’s great because I want them to keep farming. And what do you do… when you get a check? You buy a Deere.” Pixabay/Public Domain Deere & Company (NYSE:DE) manufact ...

Core Insights - A bidding war is emerging in the biotech sector, with Avadel Pharmaceuticals (AVDL) at the center, as Alkermes (ALKS) faces competition from Lundbeck for a potential acquisition [1][2] Group 1: Acquisition Offers - Lundbeck has made an unsolicited bid for Avadel worth up to $2.4 billion, valuing Avadel stock at $23 per share, which includes $21 in cash and $2 tied to contingent value rights (CVRs) [2] - Avadel previously agreed to a $2.1 billion takeover deal from Alkermes, which valued the stock at up to $20 per share, consisting of $18.50 in cash and CVRs worth up to $1.50 per share [2] Group 2: Market Reactions - Following Lundbeck's offer, Avadel's stock surged over 20% to $23.16, while Alkermes' stock fell more than 6% to $29 [4] Group 3: Financial Capacities - Alkermes has $1.1 billion in cash and no debt, with an EBITDA of $380 million, giving it a theoretical deal capacity of $2.7 billion [5] - Lundbeck has $550 million in cash and $1.9 billion in debt, with an EBITDA of $1.3 billion, resulting in a theoretical deal capacity of $3.8 billion [5] Group 4: Contingent Value Rights and Sales Milestones - Lundbeck's deal includes aggressive sales milestones requiring Lumryz and valiloxybate to achieve at least $450 million in U.S. sales annually by 2027 and $700 million before 2030 [7] - Analysts estimate Lumryz will generate $399 million in 2027 and $581 million by 2030, which is below Lundbeck's required sales milestones [7]

Celsius Holdings, Inc. (NASDAQ:CELH) is one of the stocks Jim Cramer mentioned in his latest comments. Noting that the stock declined around 25% after reporting its earnings, a caller asked if it is a good entry point. Cramer replied: “I was surprised about that miss and frankly, I didn’t understand it. I have been behind Celsius. I almost included a big part in my book about Celsius. Thank heavens, it actually didn’t get in because that was a bad miss. I think that we got to, we have to wait another quar ...

Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer mentioned in his latest comments. Cramer highlighted the company’s breakthrough medicine, as he remarked: “We had Amgen on the show the other day, announcing a breakthrough in Repatha, its every other week injection squelches cholesterol to a level where it helps prevent heart attacks. Why not go buy that?” Photo by Yiorgos Ntrahas on Unsplash Amgen Inc. (NASDAQ:AMGN) delivers human therapeutics for conditions such as cancer, cardiovascular dise ...

The Gap, Inc. (NYSE:GAP) is one of the stocks Jim Cramer mentioned in his latest comments. Cramer showed optimism in the company’s quarter, as he said: “Glum people don’t go out to dinner, do they? They hunker down and stay home, all bummed out, eating ready-made salads and whatever else they can afford from the supermarket without breaking the bank. That’s been a problem for millions of people with the federal employee furloughs and the food stamp cuts, stuff that makes us look like a banana republic. Ex ...

Group 1 - GE Aerospace is recognized for its remarkable business performance, particularly in the context of the recent government shutdown which overshadowed its quarterly results [1][2] - The company manufactures commercial and defense aircraft engines, power systems, and provides maintenance, repair, and overhaul services, along with spare parts for aviation and military applications [2] - CEO Larry Culp has been praised for successfully reinventing GE Aerospace, leading to significant financial gains for investors [2] Group 2 - Despite the positive outlook for GE Aerospace, there is a belief that certain AI stocks may offer greater upside potential and carry less downside risk [2]